How to Optimize TMT Workflow Using SPS-MS3 and Reduce Ratio Compression?

TMT (Tandem Mass Tags) is a widely used isotopic labeling technology for high-throughput protein quantification analysis, enabling parallel detection of multiple samples (currently supporting up to 18-plex). It exhibits strong advantages in disease mechanism research, drug action mechanism analysis, and clinical biomarker screening. However, ratio compression is one of the main technical bottlenecks in TMT quantification. Due to the interference of co-eluting peptides at the MS2 level, the intensity of reporter ions of target peptides is inaccurately measured, leading to an underestimation of quantification results, especially in low-abundance proteins. To overcome this challenge, the Synchronous Precursor Selection-MS3 (SPS-MS3) technology has been proposed and gradually becomes a core strategy in high-precision TMT quantification.

 

1. Causes of Ratio Compression: Analysis from the MS2 Level

In the TMT-MS2 workflow, peptides are selected at the first stage of mass spectrometry (MS1) and then enter the collision-induced dissociation (CID) or high-energy collision dissociation (HCD) stage. At this point, in addition to the target peptides, there are often co-isolated precursors, which also fragment in MS2, releasing TMT reporter ions from non-target peptides, leading to confused quantification signals and compressed true expression ratios.

 

2. Principles and Advantages of SPS-MS3

1. What is SPS-MS3?

SPS-MS3 is an advanced quantification mode developed based on the Orbitrap Tribrid platform (such as Fusion Lumos, Eclipse, etc.). The core idea is to select multiple target ions for synchronous analysis during the second fragmentation (MS3), significantly reducing co-eluting interference.

Working Mechanism:

• MS1: Selection of target peptide precursor ions
• MS2: Initial fragmentation, producing b/y ion groups
• SPS Selection: Selecting multiple high-intensity b/y ions (usually 10) from MS2 fragments
• MS3: Further fragmenting this batch of SPS-selected ions to generate TMT reporter ions for quantification

 

2. Key Advantages of SPS-MS3

• Significantly reduces ratio compression: Through quantification from multiple MS2 fragment ions rather than the original precursor, effectively excluding co-eluting interference ions
• Improves quantification accuracy and reliability: Especially sensitive in identifying differential expression in low-abundance proteins
• Enhances reproducibility: Shows more stable quantification performance in repeated experiments

 

3. How to Optimize the TMT Workflow to Maximize SPS-MS3 Efficiency?

1. Instrument Setting Optimization

(1) SPS Ion Number: It is recommended to choose 8-10 high-intensity MS2 fragments as SPS ions, avoiding interference or background ions;

(2) MS3 Resolution: Setting it to 60,000 (Orbitrap) or higher is recommended to ensure high-resolution separation of TMT reporter ions;

(3) Collision Energy (NCE): A higher NCE (such as 65-70%) is recommended in the MS3 stage to ensure sufficient release of reporter ions.

 

2. Sample Pretreatment Optimization

(1) High-pH Reverse Phase Fractionation (HpH fractionation): Improves peptide complexity control, reducing co-elution probability;

(2) Protease Cleavage Efficiency: Ensures peptide integrity and site-specific cleavage, reducing non-specific background ions;

(3) Removal of High-Abundance Proteins: In samples such as plasma or tissue, pre-removal of high-abundance interfering proteins like albumin and immunoglobulins.

 

3. Data Analysis Strategy

(1) Use Proteome Discoverer + SEQUEST/Byonic + SPS-MS3 data integration module;

(2) Use Precursor Coisolation Threshold function to assess interference levels;

(3) Combine Reporter Ion S/N ratio to filter low-quality peptides, improving data quality.

 

4. Application Scenarios for SPS-MS3 Technology

1. Deep Quantitative Analysis of Complex Tissue Samples:Such as tumor tissue, brain tissue, and other high-complexity samples;

2. Low-Abundance Protein Research:Such as screening for low-expression proteins like transcription factors and cytokines;

3. Clinical Sample Biomarker Discovery:Multi-omics clinical research with extremely high requirements for quantification accuracy;

4. Drug Mechanism Research:Analyzing dynamic protein regulatory changes before and after drug treatment.

 

TMT technology, as a powerful tool in high-throughput proteomics, can only truly realize its potential for multiplex quantification by resolving the issue of ratio compression. SPS-MS3 provides researchers with a stable and reliable solution, especially suitable for high complexity, subtle differential expression scenarios. Biotech Peak BioTech is committed to safeguarding every experimental data of yours. If you are conducting TMT quantification experiments or encountering ratio compression issues, feel free to contact our expert team for one-on-one technical support and solutions.

 

Protein analysis based on TMT